New paper out on anti-biofilm activity in Steptococcus pneumoniae!

I am so excited to announce that our newest paper on our biofilm inhibitor formulation, 220D-F2 from the Elmleaf blackberry, has been published in PLoS ONE! Here, we report exciting activity against pneumococcal biofilms! Streptococcus pneumoniae (pneumococcus) is an important human pathogen associated with high morbidity and mortality, causing serious…

Continue reading

Quave to give invited lecture at Cornell University in 2014

Dr. Quave will present a lecture entitled “Medicines from Nature: An ethnobotanical approach to anti-infective drug discovery” for the Cornell University Department of Plant Biology seminar series on March 7th, 2014. She will also be presenting a guest lecture in Dr. Eloy Rodriguez’s “Medical Ethnobotany of New World Cultures” course.…

Continue reading

Quave & collaborators awarded research grant from the National Institutes of Health

A grant proposal entitled “Mechanistic Studies on Staphylococcal Quorum Quenching Natural Products” has been selected for funding under the R01 mechanism from the National Center for Complementary and Alternative Medicine at the US National Institutes of Health. The five year research project, totaling $1.829 million dollars, will be led by…

Continue reading

Exciting new study published by Quave and colleagues

An exciting new study by Dr. Quave and colleagues reporting the activity of ellagic acid derivatives against S. aureus biofilms was published today in PLoS One. These compounds were isolated from a medicinal blackberry plant used in southern Italy to treat skin infections. The full article is accessible at this…

Continue reading